Ocular ischemic syndrome
| Ocular ischemic syndrome | |
|---|---|
| Synonyms | OIS |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Vision loss, eye pain, amaurosis fugax, retinal hemorrhage |
| Complications | Neovascularization, glaucoma, retinal detachment |
| Onset | Typically in middle-aged to elderly individuals |
| Duration | Chronic |
| Types | N/A |
| Causes | Carotid artery stenosis, atherosclerosis |
| Risks | Hypertension, diabetes mellitus, hyperlipidemia, smoking |
| Diagnosis | Fluorescein angiography, Doppler ultrasound, Ophthalmoscopy |
| Differential diagnosis | Central retinal artery occlusion, retinal vein occlusion, giant cell arteritis |
| Prevention | N/A |
| Treatment | Carotid endarterectomy, laser photocoagulation, anti-VEGF therapy |
| Medication | N/A |
| Prognosis | Variable, often poor without treatment |
| Frequency | Rare |
| Deaths | N/A |
Ocular Ischemic Syndrome (OIS) is a rare condition, typically caused by carotid artery disease, that results in reduced blood flow to the eye. This can lead to vision loss and other serious complications.
Causes[edit]
The primary cause of Ocular Ischemic Syndrome is carotid artery disease, which results in a blockage or narrowing of the carotid arteries. This can reduce blood flow to the eye, leading to the symptoms of OIS. Other potential causes include diabetes, hypertension, and atherosclerosis.
Symptoms[edit]
Symptoms of Ocular Ischemic Syndrome can vary, but often include:
Diagnosis[edit]
Diagnosis of Ocular Ischemic Syndrome typically involves a comprehensive eye examination, including a fundus examination and fluorescein angiography. Additional tests may include carotid artery ultrasound, magnetic resonance angiography (MRA), or computed tomography angiography (CTA).
Treatment[edit]
Treatment for Ocular Ischemic Syndrome is primarily aimed at improving blood flow to the eye. This can involve carotid endarterectomy, a surgical procedure to remove plaque from the carotid artery, or carotid artery stenting, a less invasive procedure that uses a stent to keep the artery open. Other treatments may include laser photocoagulation or intravitreal injections of medications to reduce swelling and improve vision.
Prognosis[edit]
The prognosis for Ocular Ischemic Syndrome can vary depending on the severity of the condition and the effectiveness of treatment. In some cases, vision loss may be permanent.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


